Kangstem Biotech Co., Ltd.

₩1,815As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:217730Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (11.29%)
Div yield —
ROE —
Biological Products, Except Diagnostic Substances
Beta (5Y) 0.43
PE TTM —
TSR TTM 25.87%
Mkt cap ₩170.7B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩2,311
27.34%
(0.40%)
Hold 7|9|1|10|5
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
21.38
22.19
24.58
26.24
21.82%
14.56%
23.58%
28.61%
Revenue₩B
8.091
8.328
8.179
8.276
9.61%
14.84%
8.02%
6.76%
Peers (US$125.9M)
Cap (US$)
PE
124.0M
—
122.7M
—
121.3M
—
Capital
TTM
5Y
10Y
Leveragex
0.759
0.226
0.187
EBIT/Intx
1.939
0.059
0.058
Own earn%
241.52
39.79
52.09
Sh yield%
15.44
59.73
58.76
Owners
Insiders/Inst%
6.37
34.16
Short interest%
0.54
SBC / revenue%
1.34
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
0–10
$1 testx
0.2
Incr. ROIC%
1